We are pleased to announce that Nevada Center for Biomedical Research (“NVCBR”) has achieved a critical milestone. The Nevada System of Higher Education Board of Regents approved a new contract resulting in the integration of NVCBR’s basic research program and its associated research assets into the University of Nevada, Reno School of Medicine’s expert research [...]
During the month of August, NVCBR held its annual community fundraiser, Cheers! We hosted approximately 150 guests at The Grove at South Creek. We are deeply grateful for the generosity of our many community members who made cash donations and/or provided us with amazing auction items and for the help of Jon Klacking of Double [...]
Up-to-date education about diseases like ME/CFS, post treatment Lyme, and fibromyalgia is vital to creating a realistic understanding of the impact that infection associated, immune-mediated diseases can have on one’s life. Education will also help others learn about the ways in which the institute is trying find the answers for these patients. To address the [...]
The National Institutes of Health determined not to renew the federal advisory committee’s charter for ME/CFS, or the CFSAC, by letting it expire. This committee was formed 16 years ago to share critical disease information and advice with the Secretary of Health. As a result, many were concerned that the NIH would no longer formally [...]
Humoral Immunity Profiling of Subjects with Myalgic Encephalomyelitis Using a Random Peptide Microarray Differentiates Cases from Controls with High Specificity and Sensitivity.
Authors: Singh S, Stafford P, Schlauch KA, Tillett RR, Gollery M, Johnston SA, Khaiboullina SF, De Meirleir KL, Rawat S, Mijatovic T, Subramanian K, Palotás A, Lombardi VC. Link: https://www.ncbi.nlm.nih.gov/pubmed/29886183 Publication: Mol Neurobiol. 2018 Jan;55(1):633-641. doi: 10.1007/s12035-016-0334-0. Epub 2016 Dec 15. Myalgic encephalomyelitis (ME) is a complex, heterogeneous illness of unknown etiology. The search for biomarkers [...]
Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.
Authors: Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, Palotás A. Link: https://www.ncbi.nlm.nih.gov/pubmed/29886183 Publication: J Nutr Biochem. 2018 Apr 19;61:1-16. doi: 10.1016/j.jnutbio.2018.04.004. [Epub ahead of print] The gut-brain axis refers to the bidirectional communication between the enteric nervous system and the central nervous system. Mounting evidence supports the premise that the intestinal microbiota [...]
Single-nucleotide polymorphisms in a cohort of significantly obese women without cardiometabolic diseases.
Authors: Schlauch KA, Kulick D, Subramanian K, De Meirleir KL, Palotás A, Lombardi VC. Link: https://www.ncbi.nlm.nih.gov/pubmed/30120429 Publication: Int J Obes (Lond). 2018 Aug 17. doi: 10.1038/s41366-018-0181-3. [Epub ahead of print] BACKGROUND/OBJECTIVES: Obesity is an important risk factor for the development of diseases such as diabetes mellitus, hypertension, and dyslipidemia; however, a small number of individuals with long-standing [...]